Evidence map›Paper›PMID 39189762›Full record

ArticleMicrobiology spectrum2024

Characterization of novel double-reporter strains of

Clara M Bento, Kevin van Calster, Tatiana Piller, Gabriel S Oliveira, Linda de Vooght, Davie Cappoen, Paul Cos, M Salomé Gomes, Tânia Silva

Abstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. BioluminescentFrontiers in cellular and infection microbiology · 2026
    Article
  2. Interplay ofVirulence · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Clara M Bentoi3S-Instituto de Investigação e Inovação e Saúde, Universidade do Porto, Porto, Portugal.ORCID 0000-0001-9019-7334
Kevin van CalsterLaboratory for Microbiology, Parasitology and Hygiene (LMPH), Wilrijk, Belgium.
Tatiana PillerLaboratory for Microbiology, Parasitology and Hygiene (LMPH), Wilrijk, Belgium.
Gabriel S Oliveirai3S-Instituto de Investigação e Inovação e Saúde, Universidade do Porto, Porto, Portugal.
Linda de VooghtLaboratory for Microbiology, Parasitology and Hygiene (LMPH), Wilrijk, Belgium.
Davie CappoenLaboratory for Microbiology, Parasitology and Hygiene (LMPH), Wilrijk, Belgium.
Paul CosLaboratory for Microbiology, Parasitology and Hygiene (LMPH), Wilrijk, Belgium.ORCID 0000-0003-4361-8911
M Salomé Gomesi3S-Instituto de Investigação e Inovação e Saúde, Universidade do Porto, Porto, Portugal.ORCID 0000-0001-7657-2118
Tânia Silvai3S-Instituto de Investigação e Inovação e Saúde, Universidade do Porto, Porto, Portugal.ORCID 0000-0002-6087-1487

Funding

Fonds Wetenschappelijk Onderzoek (FWO) 1S68720NInnovative Medicine Initiative 2 Call 16 RespiriTB 853903MEC | Fundação para a Ciência e a Tecnologia (FCT) PTDC/BIA-MIC/3458/2020
6 · The paper itself

Abstract

IMPORTANCE:

Indexed as

Drug DiscoveryMycobacterium abscessusMycobacterium Infections, NontuberculousAnimalsAnti-Bacterial AgentsGenes, ReporterHumansMicrobial Sensitivity TestsMothsAnti-Bacterial Agentsdrug screeningfluorescenceGalleria mellonellainfection modelsluminescencemacrophagesMycobacteriumreporter strains

Identifiers

PMID39189762
PMCPMC11448253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.